Comparative Clinical Analysis of Gastroenteropancreatic Neuroendocrine Carcinomas with Liver Metastasis and Primary Hepatic Neuroendocrine Carcinomas

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Primary site</td><td class="align_center">Cases</td><td class="align_center">Percentage</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Pancreas</td><td class="align_center">12</td><td class="align_center">35.29%</td></tr><tr><td class="align_left">Stomach</td><td class="align_center">11</td><td class="align_center">32.35%</td></tr><tr><td class="align_left">Gallbladder</td><td class="align_center">8</td><td class="align_center">23.53%</td></tr><tr><td class="align_left">Rectum</td><td class="align_center">2</td><td class="align_center">5.88%</td></tr><tr><td class="align_left">Cecum</td><td class="align_center">1</td><td class="align_center">2.95%</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Primary sites of gastroenteropancreatic neuroendocrine carcinomas with liver metastasis.</div>

Disease Markers

tab3

Table 3

Table 3: Comparative Clinical Analysis of Gastroenteropancreatic Neuroendocrine Carcinomas with Liver Metastasis and Primary Hepatic Neuroendocrine Carcinomas 

Table 3 | Comparative Clinical Analysis of Gastroenteropancreatic Neuroendocrine Carcinomas with Liver Metastasis and Primary Hepatic Neuroendocrine Carcinomas 